| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 85,122 | 81,014 | 87,487 | 84,376 | | Cost of Revenue | 11,062 | 11,185 | 11,232 | 11,060 | | | Gross Profit | 74,060 | 69,829 | 76,255 | 73,316 | | | Operating Expenses | | Research Development | 5,676 | (37,036) | 17,850 | 19,951 | | Selling General and Administrative | 38,672 | 33,792 | 36,094 | 35,599 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 29,712 | 73,073 | 22,311 | 17,766 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,698 | 2,206 | 2,913 | 3,437 | | Earnings Before Interest And Taxes | 31,410 | 75,279 | 25,224 | 21,203 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 31,410 | 75,279 | 25,224 | 21,203 | | Income Tax Expense | 968 |
-
| (94) |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 30,442 | 75,279 | 25,318 | 21,203 | | | Non-recurring Events | | Discontinued Operations |
-
| (51,639) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 30,442 | 23,640 | 25,318 | 21,203 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $30,442 | $23,640 | $25,318 | $21,203 |
|
0.11% Nasdaq 0.00%
Income Statement
